Data showing the consumption of antimicrobial agents in Europe since 1997. Data are collected on the consumption of antimicrobials in the primary care sector and the hospital sector of 30 EU/EEA Member States. A database allows users to view tables, maps and graphs for consumption by country and antimicrobial group. Annual reports present more in-depth data and analysis ESAC-Net is the continuation of the former ESAC project (managed by the University of Antwerp until June 2011) and is a Europe-wide network of national surveillance systems providing independent reference data on antimicrobial consumption in Europe, reported by 30 EU/EEA countries. It collects and analyses data from the community (primary care) and the hospital sector.

Data summary

• File 'ESAC-Net_report_2018_downloadable_tables.xlsx'

  • Table ‘Table_D1’ consists of 31 data rows along 15 dimensions: ‘Country’, ‘2009’, ‘2010’, ‘2011’, ‘2012’, ‘2013’, ‘2014’, ‘2015’, ‘2016’, ‘2017’ and five other dimensions
  • Table ‘Table_D2’ consists of 31 data rows along 15 dimensions: ‘Country’, ‘2009’, ‘2010’, ‘2011’, ‘2012’, ‘2013’, ‘2014’, ‘2015’, ‘2016’, ‘2017’ and five other dimensions
  • Table ‘Table_D3’ consists of 31 data rows along 15 dimensions: ‘Country’, ‘2009’, ‘2010’, ‘2011’, ‘2012’, ‘2013’, ‘2014’, ‘2015’, ‘2016’, ‘2017’ and five other dimensions
  • Table ‘Table_D4’ consists of 31 data rows along 15 dimensions: ‘Country’, ‘2009’, ‘2010’, ‘2011’, ‘2012’, ‘2013’, ‘2014’, ‘2015’, ‘2016’, ‘2017’ and five other dimensions
  • Table ‘Table_D5’ consists of 31 data rows along 15 dimensions: ‘Country’, ‘2009’, ‘2010’, ‘2011’, ‘2012’, ‘2013’, ‘2014’, ‘2015’, ‘2016’, ‘2017’ and five other dimensions
  • Table ‘Table_D6’ consists of 31 data rows along 15 dimensions: ‘Country’, ‘2009’, ‘2010’, ‘2011’, ‘2012’, ‘2013’, ‘2014’, ‘2015’, ‘2016’, ‘2017’ and five other dimensions
  • Table ‘Table_D7’ consists of 31 data rows along 15 dimensions: ‘Country’, ‘2009’, ‘2010’, ‘2011’, ‘2012’, ‘2013’, ‘2014’, ‘2015’, ‘2016’, ‘2017’ and five other dimensions
  • Table ‘Table_D8 [B3:N36]’ consists of 32 data rows along 13 dimensions: ‘Country’, ‘Consumption - J01*’, ‘Consumption - JO1C’, ‘Consumption - J01D’, ‘Consumption - J01F’, ‘Consumption - J01M’, ‘Relative consumption - J01CE_%‡’, ‘Relative consumption - J01CR_%’, ‘Relative consumption - J01DD+DE_%’, ‘Relative consumption - J01MA_%’ and three other dimensions
  • Table ‘Table_D8 [B51:N60]’ consists of nine data rows along 13 dimensions: ‘J01CE_%’, ‘J01CE_%’, ‘J01CE_%’, ‘Consumption of beta-lactamase-sensitive penicillins (J01CE) expressed as percentage of the total consumption of antibacterials for systemic use (J01)’, ‘Consumption of beta-lactamase-sensitive penicillins (J01CE) expressed as percentage of the total consumption of antibacterials for systemic use (J01)’, ‘Consumption of beta-lactamase-sensitive penicillins (J01CE) expressed as percentage of the total consumption of antibacterials for systemic use (J01)’, ‘Consumption of beta-lactamase-sensitive penicillins (J01CE) expressed as percentage of the total consumption of antibacterials for systemic use (J01)’, ‘Consumption of beta-lactamase-sensitive penicillins (J01CE) expressed as percentage of the total consumption of antibacterials for systemic use (J01)’, ‘Consumption of beta-lactamase-sensitive penicillins (J01CE) expressed as percentage of the total consumption of antibacterials for systemic use (J01)’, ‘Consumption of beta-lactamase-sensitive penicillins (J01CE) expressed as percentage of the total consumption of antibacterials for systemic use (J01)’ and three other dimensions
  • Table ‘Table_D8 [A39:C43]’ consists of four data rows along three dimensions: ‘5/2’, ‘Column B’ and ‘Values within the first quartile [p0;p25]’
  • Table ‘Table_D9’ consists of 29 data rows along four dimensions: ‘Country’, ‘Vancomycin* (A07AA09) + Fidaxomicin (A01AA12)’, ‘Rifampicin (J04AB02)’ and ‘Metronidazole (P01AB01)’
  • Table ‘Table_D10’ consists of 26 data rows along 15 dimensions: ‘Country’, ‘2009’, ‘2010’, ‘2011’, ‘2012’, ‘2013’, ‘2014’, ‘2015’, ‘2016’, ‘2017’ and five other dimensions
  • Table ‘Table_D11’ consists of 26 data rows along 15 dimensions: ‘Country’, ‘2009’, ‘2010’, ‘2011’, ‘2012’, ‘2013’, ‘2014’, ‘2015’, ‘2016’, ‘2017’ and five other dimensions
  • Table ‘Table_D12’ consists of 26 data rows along four dimensions: ‘Country’, ‘Vancomycin* (A07AA09) + Fidaxomicin (A07AA12)’, ‘Rifampicin (J04AB02)’ and ‘Metronidazole (P01AB01)’
  • Table ‘Table_D13’ consists of 26 data rows along ten dimensions: ‘Country’, ‘D01BA01 - (Griseo-fulvine)’, ‘D01BA02 - (Terbina-fine)’, ‘J02AA01 - (Ampho-tericin B)’, ‘J02AB02 - (Ketoco-nazole)’, ‘J02AC01 - (Flucona- - zole)’, ‘J02AC02 - (Itracona-zole)’, ‘J02AC03 - (Voricona-zole)’, ‘Other J02 substances’ and ‘Total - J02 & D01BA’
  • Table ‘Table_D14’ consists of 21 data rows along ten dimensions: ‘Country’, ‘D01BA01 - (Griseo-fulvine)’, ‘D01BA02 - (Terbina-fine)’, ‘J02AA01 - (Ampho-tericin B)’, ‘J02AB02 - (Ketoco-nazole)’, ‘J02AC01 - (Flucona- - zole)’, ‘J02AC02 - (Itracona-zole)’, ‘J02AC03 - (Voricona-zole)’, ‘Other J02 substances’ and ‘Total - J02 & D01BA’
  • Table ‘Table_D15’ consists of 27 data rows along ten dimensions: ‘Country’, ‘Nucleosides and nucleotides excl. reverse transcriptase inhibitors - (J05AB )’, ‘Protease inhibitors - (J05AE)’, ‘Nucleoside and nucleotide reverse transcriptase inhibitors - (J05AF)’, ‘Non-nucleoside reverse transcriptase inhibitors - (J05AG)’, ‘Neura-minidase inhibitors - (J05AH)’, ‘Antivirals for treatment of HCV infections (J05AP)’, ‘Antivirals for treatment of HIV infections, combina-tions - (J05AR)’, ‘Other antivirals - (J05AC + - J05AD + - J05AX)’ and ‘Total - (J05)’
  • Table ‘Table_D16’ consists of 27 data rows along nine dimensions: ‘Column A’, ‘HIV/AIDS antivirals’, ‘HIV/hepatitis B antivirals’, ‘Hepatitis B antivirals’, ‘Hepatitis C antivirals’, ‘Herpes antivirals’, ‘Influenza antivirals’, ‘Other antivirals’ and ‘Total’
  • Table ‘Table_D17’ consists of 28 data rows along ten dimensions: ‘Country’, ‘2014’, ‘2015’, ‘2016’, ‘2017’, ‘2018’, ‘2018’, ‘Trends in antimicrobial consumption, - 2009–2018’, ‘CAGR - Compound annual growth rate (%)’ and ‘Trend’
  • Table ‘Table_D18’ consists of 30 data rows along 23 dimensions: ‘Country’, ‘1997’, ‘1998’, ‘1999’, ‘2000’, ‘2001’, ‘2002’, ‘2003’, ‘2004’, ‘2005’ and 13 other dimensions
  • Table ‘Table_D19’ consists of 25 data rows along 23 dimensions: ‘Country’, ‘1997’, ‘1998’, ‘1999’, ‘2000’, ‘2001’, ‘2002’, ‘2003’, ‘2004’, ‘2005’ and 13 other dimensions